On February 6, 2015, the Brazilian House of Representatives reinstated bill #139/1999 and 15 other bills attached thereto1, all seeking to amend the Brazilian Patent Statute. These bills had been previously shelved due to the end of the 2014-2015 legislature.  Some of these bills seek to limit patent rights, modifying provisions concerning different aspects of the statute, such as the scope and duration of patent rights, patentable subject matter, and compulsory license. Another sensitive topic addressed by these bills is the role of the ANVISA (Brazilian equivalent to the FDA) in the examination of pharmaceutical patent applications.     If you have any questions or need additional information, please contact us at prevail@lickslegal.com.  1 Bills #3562/2000, #5176/2009, #3945/2012, #303/2003, #7066/2002, #2846/2011, #3944/2012, #5402/2013, #2511/2007, #3995/2008, #3709/2008, #7965/2010, #3943/2012, #8090/2014 and #8091/2014.

‍